Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection

Affiliations

• ¹ Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: [email protected].
• ² Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
• ³ Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
• ⁴ Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁵ Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.